Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000-until recently.

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

A retrospective study finds Medicare Advantage patients receive less advanced radiotherapy, with increased treatment duration ...

In fact, 25 percent of cervical cancer diagnoses occur in women over the age of 65, and cervical cancers diagnosed in this ...

Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased ...

No significant differences in treatment or outcomes were found between most Medicare Advantage (MA) and fee-for-service (FFS) ...

Thanks to improving medical care and collective lifestyle improvements, including a sustained decline in the number of ...

Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...

Cancer care can vary significantly from hospital to hospital, especially for patients considering clinical trials.  The quest ...

Nance, BS, and Johnie Rose, MD, PhD, of Case Western Reserve University, acknowledge key limitations of their study and ...

A new study by the Institute of Cancer Research suggests this routine scan is responsible for as many cancer cases as alcohol ...